Conclusions Postprandial hyperglycemia is an independent risk factor of atherosclerosis， and the change of atherosclerosis might have started since early IGT stage，which shows that IGT might be the risk factor of ischemic stroke.
结论 餐后高血糖是动脉粥样硬化的独立危险因素，早在糖耐量异常阶段就已经发生了颅内和颅外大血管的动脉粥样硬化，提示糖耐量异常也是脑梗死的危险因素。
参考来源 - 糖耐量异常与脑梗死患者颅内外动脉粥样硬化的相关性研究Therefore it's a worldwide problem how to prevent and control diabetes effectivelyA-glucosidase inhibitors can retard the absorption of glucose to improve postprandial hyperglycemia effectively. They are helpful for impeding the progress of diabetes and its complications.
a-葡萄糖苷酶抑制剂可以通过降低餐后血糖峰值,发挥调整血糖水平的作用,有助于控制糖尿病的发展尤其是并发症的发生,是一种有广阔应用前景的治疗糖尿病的药物。
参考来源 - 中药中aMultiple variables logistic regression analysis showed that 2h postprandial hyperglycemia decreased the scale of self-efficacy(OR=0.905,95%ACI:0.854-0.958).
多因素Logistic回归分析结果显示,高餐后2小时血糖(OR=0.905,95%CI:0.854-0.958)降低患者的自我效能。
参考来源 - 糖尿病患者的自我效能水平及其影响因素分析·2,447,543篇论文数据，部分数据来源于NoteExpress
Insulin Glargine does not treat postprandial hyperglycemia.
甘精胰岛素不能治疗餐后高血糖。
Conclusions Acarbose was an effective and safe drug in lowering postprandial hyperglycemia.
结论阿卡波糖是降低餐后高血糖的一种有效而安全的降糖药。
Objective: To investigate the postprandial hyperglycemia and cardiovascular diseases related to each other.
目的：探讨餐后高血糖与心血管疾病发生的相关性。
应用推荐